BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Z, Li T, Cui Y, Li S, Cheng C, Shen B, Le W. Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson's Disease: A Potential Disease Biomarker. Front Neurosci 2019;13:218. [PMID: 30936821 DOI: 10.3389/fnins.2019.00218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Yao L, Zheng Z, Koc S, Lu G. The Role of Non-Coding RNAs in the Pathogenesis of Parkinson’s Disease: Recent Advancement. Pharmaceuticals 2022;15:811. [DOI: 10.3390/ph15070811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Fang C, Yang Y, Zou S, Ouyang P, Qing Y, Han J, Li H, Wang Z, Du J. Signal-On Fluorescence Biosensor for Highly Sensitive Detection of miRNA-21 Based on DNAzyme Assisted Double-Hairpin Molecular Beacon. Biosensors (Basel) 2022;12:276. [PMID: 35624579 DOI: 10.3390/bios12050276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang W, Xin J, Lai J, Zhang W. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer. Immunobiology 2021;227:152163. [PMID: 34896914 DOI: 10.1016/j.imbio.2021.152163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Kuo MC, Liu SC, Hsu YF, Wu RM. The role of noncoding RNAs in Parkinson's disease: biomarkers and associations with pathogenic pathways. J Biomed Sci 2021;28:78. [PMID: 34794432 DOI: 10.1186/s12929-021-00775-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
5 Kong W, Li H, Xie L, Cui G, Gu W, Zhang H, Ma W, Zhou Y. LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p/RAB22A axis. BMC Cancer 2021;21:1069. [PMID: 34592939 DOI: 10.1186/s12885-021-08668-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Magare AC, Patel MS. Biomarkers Identification for Parkinson’s Disease using Machine Learning. 2021 International Conference on Artificial Intelligence and Machine Vision (AIMV) 2021. [DOI: 10.1109/aimv53313.2021.9670941] [Reference Citation Analysis]
7 Chis AR, Moatar AI, Dijmarescu C, Rosca C, Vorovenci RJ, Krabbendam I, Dolga A, Bejinar C, Marian C, Sirbu IO, Simu M. Plasma hsa-mir-19b is a potential LevoDopa therapy marker. J Cell Mol Med 2021. [PMID: 34328686 DOI: 10.1111/jcmm.16827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chiș AR, Moatăr AI, Sîrbu I. A Disease in Search for a Biomarker: MicroRNAs in Parkinson’s Disease. Timisoara Med 2021;2021:1. [DOI: 10.35995/tmj20210102] [Reference Citation Analysis]
9 Bi C, Zhou S, Liu X, Zhu Y, Yu J, Zhang X, Shi M, Wu R, He H, Zhan C, Lin Y, Shen B. NDDRF: A risk factor knowledgebase for personalized prevention of neurodegenerative diseases. Journal of Advanced Research 2021. [DOI: 10.1016/j.jare.2021.06.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Nies YH, Mohamad Najib NH, Lim WL, Kamaruzzaman MA, Yahaya MF, Teoh SL. MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review. Front Neurosci 2021;15:660379. [PMID: 33994934 DOI: 10.3389/fnins.2021.660379] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
11 Kamenova S, Aralbayeva A, Kondybayeva A, Akimniyazova A, Pyrkova A, Ivashchenko A. Evolutionary Changes in the Interaction of miRNA With mRNA of Candidate Genes for Parkinson's Disease. Front Genet 2021;12:647288. [PMID: 33859673 DOI: 10.3389/fgene.2021.647288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Yang Y, Li Y, Yang H, Guo J, Li N. Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease. Front Mol Neurosci 2021;14:631553. [PMID: 33762908 DOI: 10.3389/fnmol.2021.631553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Rezaei O, Nateghinia S, Estiar MA, Taheri M, Ghafouri-Fard S. Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease. Eur J Pharmacol 2021;896:173914. [PMID: 33508286 DOI: 10.1016/j.ejphar.2021.173914] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 13.0] [Reference Citation Analysis]
14 Shao Y, Li T, Liu Z, Wang X, Xu X, Li S, Xu G, Le W. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry. Mol Neurodegener 2021;16:4. [PMID: 33485385 DOI: 10.1186/s13024-021-00425-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
15 Shen B, Li K, Zhang Y. Identification of modules and novel prognostic biomarkers in liver cancer through integrated bioinformatics analysis. FEBS Open Bio 2020;10:2388-403. [PMID: 32961635 DOI: 10.1002/2211-5463.12983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Acharya S, Salgado-Somoza A, Stefanizzi FM, Lumley AI, Zhang L, Glaab E, May P, Devaux Y. Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson's Disease. Int J Mol Sci 2020;21:E6513. [PMID: 32899928 DOI: 10.3390/ijms21186513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
17 Zhang X, Zhang H, Shen B, Sun XF. Novel MicroRNA Biomarkers for Colorectal Cancer Early Diagnosis and 5-Fluorouracil Chemotherapy Resistance but Not Prognosis: A Study from Databases to AI-Assisted Verifications. Cancers (Basel) 2020;12:E341. [PMID: 32028703 DOI: 10.3390/cancers12020341] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
18 Ramaswamy P, Yadav R, Pal PK, Christopher R. Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker. Ann Indian Acad Neurol 2020;23:84-97. [PMID: 32055127 DOI: 10.4103/aian.AIAN_440_19] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Li T, Le W. Biomarkers for Parkinson's Disease: How Good Are They? Neurosci Bull 2020;36:183-94. [PMID: 31646434 DOI: 10.1007/s12264-019-00433-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 10.7] [Reference Citation Analysis]